SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance CDC is leading the , a new national genomics consortium to coordinate SARS-CoV-2 sequencing across the United States.
Large-scale, rapid genomic sequencing of the virus that causes COVID-19 will allow public health experts to With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.
The SPHERES consortium is being led by CDC’s Advanced Molecular Detection (AMD) program, which over the past six years has invested in federal, state, and local public health